EMA Authorised: Levemir (Insulin detemir) — Novo Nordisk A/S

View source ↗

Summary

EMA Authorised Levemir (insulin detemir) by Novo Nordisk A/S for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Lemvemir (insulin detemir)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Novo Nordisk A/S. Decision date: 09/04/2021